EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Niki Karachaliou, R. Jonas A. Nilsson, Jordi Berenguer, Ana Gimenez Capitan, Pepijn Schellen, Cristina Teixido, Justine Leonie Kuiper, Esther Drees, Magda Grabowska, Marte van Keulen, Jihane M. Tannous, Danielle Heideman, Erik Thunnissen, Anne-Marie C. Dingemans, Santiago Viteri Ramirez, Bakhos A. Tannous, Ana Drozdowskyj, Egbert F. Smit, Thomas Wurdinger, Rafael Rosell
Institutions: Hospital Universitario Dexeus, Cancer Center Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Harvard University, Massachusetts General Hospital, Maastricht University Medical Centre, Pivotal (Spain), Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598410844